Table 3.
Univariate Analysis | |||||||
---|---|---|---|---|---|---|---|
Multivariate Analysis | |||||||
Group A | Group B | Group C | |||||
TO and TS | TO or TS | TO and TS | B vs A | C vs A | |||
Normal | Abnormal | Abnormal | |||||
(n = 76) | (n = 30) | (n = 16) | OR | P | OR | P | |
Age (years) | 60 ± 8 | 64 ± 16a | 66 ± 8a | ||||
Age > 60 years | 37 (49%) | 21(70%)a | 12 (75%)a | 1.29 | 0.007 | 1.27 | 0.002 |
Females | 12 (16%) | 5 (17%) | 4 (25%) | ||||
Diabetes | 18 (24%) | 6 (20%) | 6 (37%) | ||||
Hypertension | 47 (63%) | 18 (60%) | 11 (69%) | ||||
MI | 48 (64%) | 23 (76%) | 12 (75%) | ||||
EF mean (%) | 52 ± 10 | 52 ± 9 | 48 ± 8 | ||||
EF < 40% | 2 (3%) | 3 (10%) | 4 (25%) | 1.39 | 0.001 | ||
Beta blockers | 66 (88%) | 25 (83%) | 14 (87%) | ||||
Calcium blockers | 7 (9%) | 5 (17%) | 3 (18%) | ||||
Statins | 64 (85%) | 21 (70%)b | 11 (69%) | 0.83 | 0.004 | 0.8 | 0.02 |
ACE inhibitors | 31 (41%) | 8 (26%) | 11 (69%) | ||||
Nitrates | 73 (97%) | 27 (90%) | 15 (94%) | 1.17 | 0.08 |
a P < 0.017; bP = 0,07 when comparing to Group A. OR: odds ratio; MI: myocardial infarction; EF: ejection fraction.
Abbrevations as in text.